The nation of Zimbabwe has declined a substantial American health deal worth $367m (£272m) spanning five years because of Washington's demand for confidential biological samples.
The decision was revealed after a internal memorandum from December was leaked, indicating that Head of State Emmerson Mnangagwa felt the deal was "skewed".
An official representative has since stated that the United States was seeking genetic material for research and commercial gain while refused to guarantee the benefits from any future vaccines.
"We are forced to start the challenging and unfortunate task of scaling back our health assistance in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont in a statement.
Her embassy said the United States had donated more than $1.9bn for health programmes to Zimbabwe over the last two decades.
A doctors' association in Zimbabwe has called for more talks to find a deal agreeable to both sides so the nation's critical HIV treatment initiative can proceed.
Wider Context
This rejection comes after a comparable situation in Kenya, where a high court halted a related health funding agreement following concerns were raised about the safety of citizens' medical information.
After resuming office recently, US President Donald Trump has slashed foreign aid and closed the US Agency for International Development (USAID).
The agency had overseen aid for the American government, but Trump stated its expenditure was "wasteful" and his administration was seeking direct bilateral agreements to enhance transparency and responsibility.
According to statements, Sixteen nations in Africa have so far signed these new agreements, representing more than $18.3bn of fresh investment.
Details of the Rejected Agreement
This assistance for Zimbabwe was intended to supported "tackling HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"It is our view this collaboration could have provided significant advantages for the people of Zimbabwe, particularly the 1.2 million presently receiving antiretroviral therapy via American-funded initiatives," Tremont added.
However, official spokesman Nick Mangwana argued the proposed deal was "asymmetrical".
"Our nation was requested to surrender its genetic material and health information indefinitely, with no corresponding assurance of benefiting from any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that could be developed from that provided information," Mangwana explained.
"Put simply, our country would supply the basic resources for medical research with no assurance that the resulting innovations would be accessible to our people should a future disease outbreak emerge."
National Interest and International Frameworks
Mangwana further noted that the American exit from the global health body and its push of bilateral deals were upending frameworks already set up through the international organization.
The spokesperson gave as an example its Pathogen Access and Benefit Sharing system designed to manage potential pandemics.
"This mechanism is designed to guarantee that when a nation provides its information, the benefits – such as medicines and cures – are shared equitably, not commercialised solely by those with the resources to develop them."
Zimbabwe's reservations over the US deal "should not be misconstrued as hostility towards the US," he added.
"We encourage further dialogue with our US partners on how future co-operation could be structured in a way that honours the sovereignty and dignity of each country."
Health Experts Reaction
Medical experts stated it recognised the official position, but recommended that talks should continue considering a large portion of the country's Aids initiatives depended on international support.
"If technical issues arise, including those involving information security or agreement terms, these can frequently be resolved through technical clarification and mutually agreed protections," the group said.
The halted deal highlights the ongoing debate between accepting vital foreign assistance and protecting national sovereignty in an increasingly interconnected world.